Prosecution Insights
Last updated: August 18, 2026

Examiner: KOVACH, KARA NICOLE

Tech Center 1600 • Art Units: 1681 1683

This examiner grants 86% of resolved cases

Performance Statistics

85.7%
Allow Rate
+25.7% vs TC avg
28
Total Applications
+100.0%
Interview Lift
1070
Avg Prosecution Days
Based on 7 resolved cases, 2023–2026

Rejection Statute Breakdown

15.8%
§101 Eligibility
14.0%
§102 Novelty
36.8%
§103 Obviousness
28.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18457634 CANCER EXAMINATION REAGENT SET, PRODUCTION METHOD FOR CANCER EXAMINATION REAGENT SET, AND CANCER EXAMINATION METHOD Final Rejection FUJIFILM Corporation
18342952 COMPOSITIONS AND METHODS FOR OLIGONUCLEOTIDE INVERSION ON ARRAYS Non-Final OA 10x Genomics, Inc.
18686822 TEMPLATE SWITCH OLIGONUCLEOTIDE (TSO) FOR MRNA 5' ANALYSIS Non-Final OA Becton, Dickinson and Company
18538441 Reusable Flow Cells Having Primer Binding Sites Comprising Reactive Sulfur Moieties and Methods of Using the Same, and Reagents for Use Therewith Non-Final OA Illumina, Inc.
18187608 CHEMICAL PLANAR ARRAY Non-Final OA ILLUMINA, INC.
18341277 METHODS AND COMPOSITIONS USEFUL IN DISCRIMINATING BETWEEN FISH SPECIES Final Rejection The Florida State University Research Foundation, Inc.
18480416 SYSTEMS AND METHODS FOR SPATIAL SCREENING OF ANALYTES Non-Final OA ULTIMA GENOMICS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month